RXQ Compounding LLC
RXQ Compounding LLC has 88 FDA recalls, 2 inspections, 0 510(k) clearances and 1 compliance action on record.
- Latest recall
- D-1689-2019 · Class II · Jun 19, 2019
- Latest inspection
- Aug 8, 2017 · OAI
Reviewing RXQ Compounding LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check RXQ Compounding LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 88 | Nov 2, 2026 | File dated Oct 27, 2026 | Current |
| 510(k) clearances | 0 | Nov 2, 2026 | File dated Oct 30, 2026 | Current |
| Inspections | 2 | Nov 7, 2026 | Newest record Oct 28, 2026 | Current |
| Compliance actions | 1 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1689-2019 | Class II | NIACINAMIDE 100MG/ML, 10ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH… | Jun 19, 2019 |
| D-1695-2019 | Class II | PREDNISOLONE 1%, MOXIFLOXACIN 0.5% OPHTH SOL, 5ML per dropper bottle, RXQ Compounding, 340 West… | Jun 19, 2019 |
| D-1679-2019 | Class II | METHYLCOBALAMIN (PFV) 10 MG/ML INJECTABLE, 10 ML per vial, RXQ Compounding, 340 West State Street… | Jun 19, 2019 |
| D-1686-2019 | Class II | MORPHINE 1MG/ML IN NACL 0.9% 55ML SYR (C-II), 55 ML per vial, RXQ Compounding, 340 West State… | Jun 19, 2019 |
| D-1657-2019 | Class II | EPINEPHrine 1:1000 INJECTION SOLUTION (PF) Syringe, 1 ML per syringe, RXQ Compounding, 340 West… | Jun 19, 2019 |
| D-1660-2019 | Class II | FOLIC ACID 10MG/ML INJECTION SOLUTION (MDV), 5 ML per vial, RXQ Compounding, 340 West State Street… | Jun 19, 2019 |
| D-1666-2019 | Class II | HYDROXOCOBALAMIN 1000 MCG/ML (PFV), 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9… | Jun 19, 2019 |
| D-1665-2019 | Class II | HYDROMORPHONE 0.2MG/ML IN NACL 0.9% SYR (C-II) , [a) 50 ML NDC 70731-0114-89; b) 55 ML NDC… | Jun 19, 2019 |
| D-1704-2019 | Class II | SODIUM BICARBONATE 8.4% (1 MEQ/ML) INJ SOLN (PFV), 50 ML PER VIAL, RXQ Compounding, 340 West State… | Jun 19, 2019 |
| D-1719-2019 | Class II | ZINC SULFATE 1MG/ML INJECTION SOLUTION, 30ML per VIAL, RXQ Compounding, 340 West State Street, Unit… | Jun 19, 2019 |
| D-1670-2019 | Class II | KETAMINE 10 MG/ML INJ SOL SYR (C-III), [a) 2 ML NDC: 70731-0132-02; b) 5 ML NDC: 70731-0132-05] per… | Jun 19, 2019 |
| D-1714-2019 | Class II | TURBO DROPS (PHEN 10% / CYCLO 1%/ TROP 1%/ KETO 0.5%) OPHTH SOLN, 5 ML per dropper bottle, RXQ… | Jun 19, 2019 |
| D-1681-2019 | Class II | MIC B12 W/B6 (LIPOSTAT PLUS) 25/50/50/1/.175 MG/ML, 30 ML per vial, RXQ Compounding, 340 West State… | Jun 19, 2019 |
| D-1653-2019 | Class II | EDETATE DISODIUM 15% INJECTABLE, 100 ML per vial, RXQ Compounding, 340 West State Street, Unit 9… | Jun 19, 2019 |
| D-1676-2019 | Class II | MANGANESE SULFATE MONOHYDRATE (PFV) 0.1MG/ML INJ, 10 ML per syringe, RXQ Compounding, 340 West State… | Jun 19, 2019 |
| D-1662-2019 | Class II | GLUTATHIONE 200MG/ML (PFV) INJECTION SOLN, 10 ML per vial, RXQ Compounding, 340 West State Street… | Jun 19, 2019 |
| D-1716-2019 | Class II | VITAMIN B COMPLEX 100 (MDV), 30 ML per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens… | Jun 19, 2019 |
| D-1717-2019 | Class II | VITAMIN B COMPLEX 100 (PFV), [2 or 30 ML] per Vial, RXQ Compounding, 340 West State Street, Unit 9… | Jun 19, 2019 |
| D-1659-2019 | Class II | FENTANYL 2MCG/ML BUPIVACAINE 0.125% IN NACL 0.9% SRY C-II, 50ML per syringe (C-II) RXQ Compounding… | Jun 19, 2019 |
| D-1684-2019 | Class II | MITOMYCIN 0.04% (PF) OPH SOLN, 1ML per syringe, RXQ Compounding, 340 West State Street, Unit 9… | Jun 19, 2019 |
Recent FDA Inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Aug 8, 2017 | Albany, OH | Drugs | Official Action Indicated (OAI) | 3011509553 |
| Sep 21, 2015 | Albany, OH | Drugs | Official Action Indicated (OAI) | 3011509553 |